Neurodivergence In The 21st Century: How Technology Supports Children's Potential [Forbes]
Akili, Inc. (AKLI)
Company Research
Source: Forbes
Around of the U.S. population is considered "neurodivergent"—an umbrella term encompassing a spectrum of neurological conditions, such as ADHD, autism, dyspraxia, dyslexia and more, that deviate from typical cognitive, emotional and behavioral patterns. Despite the prevalence of neurodivergence, society is prone to stigmatize—fixating on the deficits rather than recognizing the richness of neurodiverse experiences and unique talents. By reframing attitudes toward neurodivergence around "uniqueness" rather than strengths and weaknesses, society can help its neurodivergent members embrace their differences and achieve optimal outcomes. The Diagnostic and Statistical Manual of Mental Disorders (DSM-5) serves as the guide for mental health diagnosis. However, with the advent of personalized medicine and precision neuropsychiatry, there is a growing recognition that individuals may not fit neatly into diagnostic categories. Technology can play a pivotal role in this paradigm shift by
Show less
Read more
Impact Snapshot
Event Time:
AKLI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AKLI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AKLI alerts
High impacting Akili, Inc. news events
Weekly update
A roundup of the hottest topics
AKLI
News
- Innosphere starts paediatric clinical trial for Novostim ADHD device [Yahoo! Finance]Yahoo! Finance
- Akili Announces Amended Agreement with Shionogi, Shift in Corporate Strategy and Release Date for First Quarter 2024 Financial Results [Yahoo! Finance]Yahoo! Finance
- Akili Announces Amended Agreement with Shionogi, Shift in Corporate Strategy and Release Date for First Quarter 2024 Financial ResultsBusiness Wire
- Akili Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag [Yahoo! Finance]Yahoo! Finance
- Akili Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update [Yahoo! Finance]Yahoo! Finance
AKLI
Sec Filings
- 5/6/24 - Form 4
- 5/6/24 - Form 4
- 4/30/24 - Form 8-K
- AKLI's page on the SEC website